UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Delay discounting by depressed and non-depressed adolescent smokers and non-smokers

Drug and alcohol dependence, 2014-02, Vol.135, p.152-155

2014

Volltextzugriff (PDF)

Evaluation of Pediatric Human Papillomavirus Vaccination Provider Counseling Written Materials: A Health Literacy Perspective

Academic pediatrics, 2018-03, Vol.18 (2), p.S28-S36

2018

Volltextzugriff (PDF)

A Pilot Study of Home‐Based Smoking Cessation Programs for Rural, Appalachian, Pregnant Smokers

Journal of obstetric, gynecologic, and neonatal nursing, 2015-03, Vol.44 (2), p.236-245

2015

Volltextzugriff (PDF)

Racial disparities in clinic follow‐up early in life among survivors of congenital heart disease

Congenital heart disease, 2019-03, Vol.14 (2), p.305-310

2019

Volltextzugriff (PDF)

A Feasibility Study of Home-Based Contingency Management With Adolescent Smokers of Rural Appalachia

Experimental and clinical psychopharmacology, 2015-12, Vol.23 (6), p.486-493

2015

Volltextzugriff (PDF)

Dimensions of Impulsive Behavior and Treatment Outcomes for Adolescent Smokers

Experimental and clinical psychopharmacology, 2014-02, Vol.22 (1), p.57-64

2014

Volltextzugriff (PDF)

Delay discounting and self-reported impulsivity in adolescent smokers and nonsmokers living in rural Appalachia

The American journal on addictions, 2015-09, Vol.24 (6), p.492-494

2015

Volltextzugriff (PDF)

A comparative study of risk-taking, autonomy, endurance, internal control and performance levels for scuba divers, vintage car racers and control group males

Legardy-Harris, Millie A

1988

Volltextzugriff (PDF)

Prayer

The Young Woman's Journal, 1915, Vol.26 (8), p.479

Harris, Millie

1915

Volltextzugriff (PDF)

PSYCHOLOGICAL ASPECTS OF ESSENTIAL HYPERTENSION

LEGARDY-HARRIS, MILLIE A

1983

Volltextzugriff (PDF)

Su1537: INFLAMMATION ON INDEX BIOPSY PREDICTS LOSS OF REMISSION AMONG ULCERATIVE COLITIS PATIENTS WITH ENDOSCOPIC REMISSION: A US COHORT ANALYSIS

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-619-S-620

2022

Volltextzugriff (PDF)

Transfer of noncoding DNA drives regulatory rewiring in bacteria

Proceedings of the National Academy of Sciences - PNAS, 2014-11, Vol.111 (45), p.16112-16117

2014

Volltextzugriff (PDF)

Factors Predicting Loss of Remission in Crohn’s Disease Patients in Endoscopic Remission in the Real World: Results From TARGET-IBD

Journal of clinical gastroenterology, 2024-05

2024

Volltextzugriff (PDF)

P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis

The American journal of gastroenterology, 2021-12, Vol.116 (Suppl 1), p.S9-S10

2021

Volltextzugriff (PDF)

The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer

Cancer Immunology, Immunotherapy : CII, 2024-07, Vol.73 (9), p.172, Article 172

2024

Volltextzugriff (PDF)

Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension Analyses

Clinical gastroenterology and hepatology, 2024-05, Vol.22 (5), p.1067-1076.e3

2024

Volltextzugriff (PDF)

P027 Factors Associated with Biologic Discontinuation in Patients with Inflammatory Bowel Disease in TARGET-IBD

The American journal of gastroenterology, 2020-12, Vol.115 (Suppl 1), p.S7-S7

2020

Volltextzugriff (PDF)

S730 Ozanimod Is an Efficacious Oral Therapy After 5-ASA Failure in Immunomodulator- and Biologic-Naive Patients With Ulcerative Colitis: Post Hoc Analysis From True North

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e512-e513

2022

Volltextzugriff (PDF)

15: LONG-TERM CARDIAC SAFETY OF OZANIMOD IN PHASE 3 CLINICAL PROGRAM OF ULCERATIVE COLITIS AND RELAPSING MULTIPLE SCLEROSIS

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-5-S-6

2022

Volltextzugriff (PDF)

S732 Ozanimod Is an Effective Oral Treatment for Patients With Ulcerative Colitis Regardless of Moderate orSevere Endoscopic Disease Activity at Baseline: A Post Hoc Analysis of the Phase 3 True North Study

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e514-e515

2022

Volltextzugriff (PDF)

Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2018-10, Vol.124, p.76-85

2018

Volltextzugriff (PDF)

Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants

Clinical pharmacokinetics, 2021-12, Vol.60 (12), p.1591-1604

2021

Volltextzugriff (PDF)

n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial

Vascular medicine (London, England), 2013-10, Vol.18 (5), p.263-274

2013

Volltextzugriff (PDF)

Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections

The Pediatric infectious disease journal, 2011-10, Vol.30 (10), p.844-849

2011

Volltextzugriff (PDF)

P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis

The American journal of gastroenterology, 2021-12, Vol.116 (Suppl 1), p.S9

2021

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(24)

Publikationsform

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Delay discounting by depressed and non-depressed adolescent smokers and non-smokers

Evaluation of Pediatric Human Papillomavirus Vaccination Provider Counseling Written Materials: A Health Literacy Perspective

A Pilot Study of Home‐Based Smoking Cessation Programs for Rural, Appalachian, Pregnant Smokers

Racial disparities in clinic follow‐up early in life among survivors of congenital heart disease

A Feasibility Study of Home-Based Contingency Management With Adolescent Smokers of Rural Appalachia

Dimensions of Impulsive Behavior and Treatment Outcomes for Adolescent Smokers

Delay discounting and self-reported impulsivity in adolescent smokers and nonsmokers living in rural Appalachia

A comparative study of risk-taking, autonomy, endurance, internal control and performance levels for scuba divers, vintage car racers and control group males

Prayer

PSYCHOLOGICAL ASPECTS OF ESSENTIAL HYPERTENSION

Su1537: INFLAMMATION ON INDEX BIOPSY PREDICTS LOSS OF REMISSION AMONG ULCERATIVE COLITIS PATIENTS WITH ENDOSCOPIC REMISSION: A US COHORT ANALYSIS

Transfer of noncoding DNA drives regulatory rewiring in bacteria

Factors Predicting Loss of Remission in Crohn’s Disease Patients in Endoscopic Remission in the Real World: Results From TARGET-IBD

P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis

The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer

Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension Analyses

P027 Factors Associated with Biologic Discontinuation in Patients with Inflammatory Bowel Disease in TARGET-IBD

S730 Ozanimod Is an Efficacious Oral Therapy After 5-ASA Failure in Immunomodulator- and Biologic-Naive Patients With Ulcerative Colitis: Post Hoc Analysis From True North

15: LONG-TERM CARDIAC SAFETY OF OZANIMOD IN PHASE 3 CLINICAL PROGRAM OF ULCERATIVE COLITIS AND RELAPSING MULTIPLE SCLEROSIS

S732 Ozanimod Is an Effective Oral Treatment for Patients With Ulcerative Colitis Regardless of Moderate orSevere Endoscopic Disease Activity at Baseline: A Post Hoc Analysis of the Phase 3 True North Study

Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer

Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants

n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial

Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections

P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis

Suchergebnisse filtern